ArticleJournal of cancer research and clinical oncology2011

Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS.

Lingyun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.